Health Products

TARO-Bupropion XL (2021-09-13)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III

Summary

Product

TARO-Bupropion XL

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
AB88254
Recalling Firm
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
TARO-Bupropion XLDIN 02475812Tablet Bupropion Hydrochloride 300 mg

Reason

Affected lot may contain black powder in the bottle from charcoal in the desiccant canister.

Depth of distribution

Wholesalers, Retailers.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime